Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Fortune

The unique free rein U.S. rail companies enjoy has led to disastrous accidents. Now they’re preparing to ship even more hazardous materials through our communities

Several industries transport hazardous substances. What sets rail apart is the unilateral decision-making and unwillingness to work with first responders.

Fortune

Inside Microsoft's strategy shift at venture arm M12

As Microsoft angles to beat rivals in hot areas like A.I., it's redesigning its venture arm to cleave more closely to the mothership. But the new direction has prompted some tough conversations.

Fortune

How New Balance plans to become a $10 billion brand

The running brand is pushing into other sports and luxury collaborations as it tries to catch Nike.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

That raspy cough you have might not be COVID. Here’s how to determine if it’s another virus raging this winter

Unfortunately, you can't, experts tell Fortune. But testing to determine which you have is still important, in order to determine the best treatment plan, they say.

Fortune

Authorities are investigating seven runway incursions which have happened in 2023

Investigations across the U.S. are piling up as the Federal Aviation Administration has already classified some incidents as having "significant potential for collision".

Fortune

99% of borrowers have a mortgage rate lower than 6%

99% of borrowers have a mortgage rate lower than 6%.

Fortune

No, Elon Musk can’t put chips into people’s brains: Regulators rejected Neuralink’s device due to safety risks, report says

Neuralink’s human brain chip trials have been put on hold after the FDA rejected the startup’s application owing to safety issues, Reuters reported Thursday.

Fortune

Read news from The Economist, FT, and more,
with one subscription

An FDA panel has recommended a 2-dose RSV vaccine for older Americans. Here’s when they might be able to get it

The jabs could be ready as soon as this summer, one expert tells Fortune.

Fortune

Read 2 of Databricks’ pitch decks

The data management startup has raised billions of dollars from a16z and others. Here’s how the team first pitched investors on their cloud-based vision.

Fortune

How Databricks became an A.I. sensation

Databricks placed a huge bet on the power of machine learning 10 years ago. That’s positioned the company as a rarity in the current market: a stable decacorn.

Fortune

How an Egyptian nonprofit leader is turning vocational education from a backup plan into a first choice

The Ghabbour Foundation trains students for the international future of the auto industry.

Fortune

NACD: ‘New universal proxy card rules and growing access to proxy voting will sow disorder in the boardroom–but bring enlightenment in the long term’

'Let this new wave of shareholder activism be a wake-up call to us all,' says the president of the National Association of Corporate Directors.

Fortune

The lessons Britain's only blind CEO learned about leadership from losing her sight in her 40s

Despite being given the heads up decades prior, she felt ill-prepared - not so much on not being able to see, but more on how she would be seen.

Fortune

The forced return to the office could be fueling the rise of labor unions

Bosses are trying to impose a return to the office–but failing to recognize that remote work enables worker power without the intermediate of a union.

Fortune

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

Dallas Fed: Housing market could see 'severe price correction'

The housing bubble hypothesis merits attention, says the Dallas Fed

Fortune

GM is cutting hundreds of jobs in a $2 billion push to ‘focus on our own efficiency’

GM is the latest company to double down on an efficiency push as automakers brace for industry-moving changes.

Fortune

Activists should sail away from their doomed attack on Benioff’s Salesforce

The activist investors targeting Salesforce don't have Marc Benioff's track record. Here's why the Salesforce CEO will outflank them.

Fortune

Who is Monkey? The notorious crypto scammer has disappeared

The mainstream rise of NFTs has created a paradise for phishing schemes.

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

Will artificial intelligence replace your lawyer–and will its name be Harvey?

While you and I might want do-it-yourself law, the clients of the firms that are Harvey’s target market do not.

Fortune

Salesforce reportedly pays actor Matthew McConaughey $10m a year despite layoffs

McConaughey has reportedly been involved in "high-level corporate discussions" as well as fronting multi-million dollar adverts.

Fortune

Gaming-focused DAO Game7 launching tool to help minimize freeloading token holders

The tool, Summon, aims to reward DAO members for participating through the use of a soul-bound token.

Fortune

YouTube's unusual 'wartime' CEO

Mohan may not have the fiery demeanor of some of his fellow internet platform CEOs, but insiders warn that it's a mistake to underestimate him.

Fortune

Tech giant Salesforce is caught in a war with employees that sums up the pandemic workplace

It’s not the first time Marc Benioff has suggested remote work was bad for productivity.

Fortune

Artificial intelligence is transforming the function of finance–and turning accountants into innovators, according to Microsoft

By embracing technology, finance teams can demonstrate their value, drive growth, and overcome the perception of being a barrier to innovation.

Fortune

It takes an average of 8 years for a rare disease patient to get diagnosed. Why is it so hard to get life-altering genetic testing in the U.S.?

An increasingly inexpensive genetic test stands in the way of a diagnosis for many rare disease patients, who are as common as one in 10 worldwide.

1 … 309 310 311 312

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.